The JULI Registry--Hemp and Cannabis Observational Registry
Status unconfirmed
Conditions studied: Chronic Pain, Appetite Disorders, Neuropathy, Menopausal Syndrome, Anxiety, Sleep Disturbance, Nausea
In brief
The JuLi Registry seeks to fill some of the gaps associated with the clinical use of CBD (cannabidiol) and other cannabinoid formulations including THC and others. The overarching goal of this Registry is to rapidly advance research and understanding of the use of cannabis and hemp-based formulations, in the clinical community setting, when it is utilized to manage the symptoms of cancer treatment and other underlying health issues. These symptoms include nausea, neuropathy, and sleeplessness and chronic pain.
Key facts
- Study ID
- NCT04726254
- Run by
- Juva Life
- People needed
- 2000
- Starts
- 2021-08-01
- Expected to finish
- 2025-02-15
- Last updated by the study team
- 2022-07-19
Who can join
Age: 21 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- 21 years of age or older
- Have requested from and/or decided with their providers to try CBD (hemp-based) or other cannabis products to relieve one or more symptoms related to a medical diagnosis
- Consent to have their health data included in a Registry and participate in PRO (patient reported outcomes) surveys and data collection via a study app.
You may not qualify if…
- Patient pregnant
- Unwilling or unable to provide informed consent
Where it is running
- Precision Cancer Specialists — Los Gatos, California, United States (enrolling)
- Justin Lo MD — San Jose, California, United States (enrolling)
- Nashville Breast Center — Nashville, Tennessee, United States (enrolling)
- Dallas Surgical Group — Dallas, Texas, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.